Format

Send to

Choose Destination
See comment in PubMed Commons below
Annu Rev Med. 2008;59:163-75. doi: 10.1146/annurev.med.59.110106.132016.

Expanded newborn screening: implications for genomic medicine.

Author information

  • 1Departments of Human Genetics and Pediatrics, David Geffen School of Medicine at the University of California, Los Angeles 90095, USA. lmccabe@mednet.ucla.edu

Abstract

Newborn screening (NBS) represents the largest volume of genetic testing. The 45-year history of NBS has demonstrated its benefits, as well as the importance of an evidence base. The recent addition of tandem mass spectrometry (MS/MS) resulted in a fivefold increase in the number of tests. Experience with MS/MS also showed that laboratory tests are just one part of the NBS system. The lessons learned from NBS will provide important insights as we move into the predictive, preventive, and personalized era of genomic medicine.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Write to the Help Desk